Subtype
Neck Carcinoma
CI-CAN-00003406Explore in graph →
464 active trials9 approved drugs55 evidence items
- NCIt
- C6077
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003406Explore in graph →
Clinical trials
1,419 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (128)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04547088 | Camrelizumab Combined With Apatinib in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma | unknown | Phase 2 | 27 | Sun Yat-sen UniversityOTHER | 1 | Sep 14, 2020 | clinicaltrials |
| NCT04548271 | Camrelizumab Combined With Apatinib in Patients With PD-1 Antagonists Resistant Recurrent/Metastatic Nasopharyngeal Carcinoma | unknown | Phase 2 | 25 | Sun Yat-sen UniversityOTHER | 1 | Sep 14, 2020 | clinicaltrials |
| NCT04538547 | Randomized Trial to Evaluate Accelerated Radiotherapy in Locally Advanced Carcinoma of Nasopharynx(EARN) | unknown | N/A | 120 | Post Graduate Institute of Medical Education and Research, ChandigarhOTHER | 1 | Sep 4, 2020 | clinicaltrials |
| NCT04534855 | A Phase II Clinical Study of Treprilimab in the Treatment of Recurrent Nasopharyngeal Carcinoma After Re-irradiation | unknown | Phase 2 | 40 | Sun Yat-sen UniversityOTHER | 0 | Sep 1, 2020 | clinicaltrials |
| NCT02476669 | Serial Plasma EBV DNA for Nasopharyngeal Carcinoma | unknown | — | 900 | The University of Hong KongOTHER | 1 | Aug 14, 2020 | clinicaltrials |
| NCT03648697 | EBV-TCR-T（YT-E001）for Patients With EBV-positive Recurrent or Metastatic NPC | unknown | Phase 2 | 20 | Fujian Cancer HospitalOTHER_GOV | 1 | Aug 11, 2020 | clinicaltrials |
| NCT03720340 | Interleukin-11 Can Prevent and Treat of Radioactive Oral Mucitis | unknown | Phase 3 | 300 | Zhejiang Cancer HospitalOTHER | 1 | Aug 11, 2020 | clinicaltrials |
| NCT04292990 | Comparison of Transdermal Fentanyl and Morphine for Oral Mucositis Pain in Nasopharyngeal Cancer Patients | unknown | Phase 4 | 300 | Jiarong Chen, MDOTHER | 0 | Jul 29, 2020 | clinicaltrials |
| NCT04472403 | Platinum Plus Low-dose Long-term Continuous Intravenous Infused 5-Fluorouracil in Metastatic Nasopharyngeal Carcinoma | unknown | — | 2,000 | Sun Yat-sen UniversityOTHER | 1 | Jul 20, 2020 | clinicaltrials |
| NCT04076514 | The Role of Central Neck Dissection in Stage N0 Papillary Thyroid Carcinoma(pCND) | unknown | — | 20 | Assiut UniversityOTHER | 1 | Jul 14, 2020 | clinicaltrials |
| NCT04447326 | Toripalimab, Endostar Combined With Radiotherapy and Chemotherapy for Nasopharyngeal Carcinoma | unknown | Phase 2 | 106 | First Affiliated Hospital of Guangxi Medical UniversityOTHER | 0 | Jun 25, 2020 | clinicaltrials |
| NCT04447612 | Concurrent Chemoradiation and Durvalumab for Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | Phase 2 | 118 | The University of Hong KongOTHER | 1 | Jun 25, 2020 | clinicaltrials |
| NCT04303975 | The Association of hsCRP and Radiotherapy-Induced Toxicity in Patients With Nasopharyngeal Carcinoma | unknown | — | 300 | Jiarong Chen, MDOTHER | 0 | Jun 11, 2020 | clinicaltrials |
| NCT04424485 | Near-infrared Fluorescence With Indocyanine Green for Identification of Sentinels and Parathyroids During Thyroidectomy | unknown | N/A | 100 | Umraniye Education and Research HospitalOTHER_GOV | 1 | Jun 11, 2020 | clinicaltrials |
| NCT04421469 | Triprilimab(JS001) and Chemotherapy Combined With Local Treatment for Multiple Metastatic NPC | unknown | Phase 2 | 39 | Fujian Cancer HospitalOTHER_GOV | 1 | Jun 9, 2020 | clinicaltrials |
| NCT04419324 | To Evaluate Transoral Flexible Endoscope With Narrow Band Imaging in Nasopharyngeal Cancer | unknown | N/A | 40 | Chinese University of Hong KongOTHER | 0 | Jun 5, 2020 | clinicaltrials |
| NCT04414566 | Induction Chemotherapy Plus Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | Phase 3 | 562 | West China HospitalOTHER | 1 | Jun 4, 2020 | clinicaltrials |
| NCT04411290 | Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid Diseases | unknown | — | 200 | Umraniye Education and Research HospitalOTHER_GOV | 1 | Jun 2, 2020 | clinicaltrials |
| NCT04396912 | Post-thyroidectomy Vocal Cord Paralysis Along With Hypocalcemia: STROBE - Guided Prospective Cohort | unknown | — | 100 | Umraniye Education and Research HospitalOTHER_GOV | 1 | May 21, 2020 | clinicaltrials |
| NCT04394091 | Post-treatment Ultrasensitive Positron Emission Tomography in Nasopharyngeal Carcinoma Patients | unknown | — | 30 | Sun Yat-sen UniversityOTHER | 1 | May 19, 2020 | clinicaltrials |
| NCT04061278 | A Multicenter, Prospective, Phase III Randomized Controlled Clinical Study for the Treatment of N2-3 Nasopharyngeal Carcinoma Patients | unknown | Phase 3 | 246 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | May 12, 2020 | clinicaltrials |
| NCT02111460 | Chemotherapy Combined With Radiotherapy vs Chemotherapy Alone for Distant Metastatic Nasopharyngeal Carcinoma | unknown | Phase 3 | 126 | Sun Yat-sen UniversityOTHER | 1 | May 8, 2020 | clinicaltrials |
| NCT04351282 | SBRT for Oligo-metastatic Lesions After Systemic Treatment of Primary Metastatic Nasopharyngeal Carcinoma | unknown | N/A | 43 | Fudan UniversityOTHER | 1 | Apr 17, 2020 | clinicaltrials |
| NCT04336696 | Is Routine Dissection of Central Lymph Node Necessary for Papillary Thyroid Carcinoma, T1-2 N0? | unknown | N/A | 199 | Bassem Mohamed SiedaOTHER_GOV | 1 | Apr 7, 2020 | clinicaltrials |
| NCT03689556 | Examine the Prognostic Role of FLT PET/CT for Patients With LR-NPC Treated by Carbon Ion Therapy | unknown | — | 40 | Shanghai Proton and Heavy Ion CenterOTHER | 0 | Apr 6, 2020 | clinicaltrials |
| NCT04319471 | Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma | unknown | Phase 2 | 70 | Fujian Cancer HospitalOTHER_GOV | 1 | Mar 24, 2020 | clinicaltrials |
| NCT04296747 | Toripalimab in Combination With Chemotherapy as Induced Chemotherapy for Localized Hypopharyngeal Cancer | unknown | Phase 2 | 100 | Peking Union Medical College HospitalOTHER | 0 | Mar 5, 2020 | clinicaltrials |
| NCT03923842 | Denosumab In Ebv Nasopharyngeal Carcinoma As A Model For RankMediated Immunologic Modulation Of Virus-Related Tumours(Dern) | unknown | Phase 2 | 45 | Gruppo Oncologico del Nord-OvestOTHER | 1 | Feb 17, 2020 | clinicaltrials |
| NCT04222543 | Imaging of Tumour Microenvironment in Patients With Oropharyngeal Head and Neck Squamous Cell Carcinoma Using RGD PET/CT Imaging(PIVOT) | unknown | Phase 2 | 20 | Radboud University Medical CenterOTHER | 1 | Jan 10, 2020 | clinicaltrials |
| NCT04220528 | Radical Radiotherapy and Chemotherapy Combined With Maintenance Chemotherapy in the Treatment of Stage N3 NPC | unknown | Phase 2 | 129 | Fujian Cancer HospitalOTHER_GOV | 1 | Jan 7, 2020 | clinicaltrials |
| NCT04158518 | De-escalation Protocols in Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | N/A | 118 | Chaosu HuOTHER | 1 | Nov 8, 2019 | clinicaltrials |
| NCT03830996 | Weekly Plasma EBV DNA for Non-metastatic Nasopharyngeal Carcinoma | unknown | — | 100 | The University of Hong KongOTHER | 1 | Oct 1, 2019 | clinicaltrials |
| NCT04107142 | Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour | unknown | Phase 1 | 10 | CytoMed Therapeutics Pte LtdINDUSTRY | 1 | Sep 27, 2019 | clinicaltrials |
| NCT03925896 | Phase I Trial of LMP2 Antigen-specific TCR T-cell Therapy for Recurrent and Metastatic NPC Patients | unknown | Phase 1 | 27 | Sun Yat-sen UniversityOTHER | 1 | Sep 12, 2019 | clinicaltrials |
| NCT03020329 | Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | Phase 2 | 37 | Sun Yat-sen UniversityOTHER | 1 | Aug 7, 2019 | clinicaltrials |
| NCT04015661 | Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Patients With LA-NPC | unknown | Phase 2 | 92 | Fuzhou General HospitalOTHER | 1 | Jul 11, 2019 | clinicaltrials |
| NCT04014738 | The Prognostic Value of Human Papilloma Virus in Nasopharyngeal Carcinoma | unknown | — | 100 | Rambam Health Care CampusOTHER | 1 | Jul 10, 2019 | clinicaltrials |
| NCT04012502 | De-escalation Protocols in HPV-related Oropharyngeal Carcinoma in Chinese Populations | unknown | N/A | 83 | Fudan UniversityOTHER | 1 | Jul 9, 2019 | clinicaltrials |
| NCT03403829 | Maintenance Chemotherapy in High-metastatic Risk Nasopharyngeal Carcinoma Patients of N3 Stage | unknown | Phase 3 | 360 | Fudan UniversityOTHER | 1 | Jul 8, 2019 | clinicaltrials |
| NCT02958111 | Single-agent Capecitabine as Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma(CAN) | unknown | Phase 3 | 406 | Sun Yat-sen UniversityOTHER | 1 | Jun 12, 2019 | clinicaltrials |
| NCT03932266 | Endostar Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy for Locoregional Nasopharyngeal Carcinoma | unknown | Phase 2 | 73 | Jiangsu Cancer Institute & HospitalOTHER | 0 | Apr 30, 2019 | clinicaltrials |
| NCT03889769 | Evaluation of Accuracy of One-Step Nucleic Acid Amplification (OSNA) in Diagnosis of Lymph Node Metastases of Papillary Thyroid Carcinoma | unknown | — | 50 | University of CagliariOTHER | 1 | Mar 26, 2019 | clinicaltrials |
| NCT03601975 | Gemcitabine and Cisplatin With/Without Anlotinib in Advanced Nasopharyngeal Carcinoma | unknown | Phase 3 | 336 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Feb 4, 2019 | clinicaltrials |
| NCT03557112 | By Comparing TPF Induction Chemotherapy Combined With Nimotuzumab Concurrent Radiotherapy and Cisplatin Concurrent Radio-chemotherapy for Locally Advanced NPC | unknown | Phase 2 | 180 | Guiyang Medical UniversityOTHER | 1 | Nov 2, 2018 | clinicaltrials |
| NCT03727594 | Radioguided Selective Neck Dissection for Staging and Treatment of Oral Cavity and Oropharyngeal Squamous Cell Carcinoma | unknown | — | 50 | University Hospital of FerraraOTHER | 1 | Nov 1, 2018 | clinicaltrials |
| NCT03723343 | GP-induced Chemotherapy Combined With IMRT and TPF-induced Chemotherapy Combined With IMRT in the Treatment of Distant Metastatic Nasopharyngeal Carcinoma | unknown | — | 146 | Guiyang Medical UniversityOTHER | 1 | Oct 29, 2018 | clinicaltrials |
| NCT03701451 | Demethylated Drug in the Treatment of Nasopharyngeal Carcinoma | unknown | Phase 1 / Phase 2 | 30 | Wei JiangOTHER | 1 | Oct 10, 2018 | clinicaltrials |
| NCT03411187 | Study on the Application of Convenient Foot-control Exhaust Method in Endoscopic Thyroidectomy | unknown | N/A | 100 | Bo Wang,MDOTHER | 1 | Sep 18, 2018 | clinicaltrials |
| NCT03454477 | Comparison Between Robotic, Endoscopic and Traditional Open Surgery in Thyroidectomy | unknown | N/A | 90 | Fujian Medical UniversityOTHER | 1 | Sep 18, 2018 | clinicaltrials |
| NCT03639467 | Study of Anlotinib Combined With Gemcitabine/Cisplatin in Advanced Nasopharyngeal Carcinoma | unknown | Phase 1 / Phase 2 | 40 | Chinese Academy of Medical SciencesOTHER | 1 | Sep 18, 2018 | clinicaltrials |
Data updated 23 days agoSource updated Sep 14, 2020source: clinicaltrials